"Dec. 11, 2012 -- The diabetes and obesity epidemics may be fueling a dramatic rise in the number of people with vision problems, a new study suggests.
Rates of vision problems that can't be treated with glasses or contact lenses, know"...
ZYMAXID™ (gatifloxacin ophthalmic solution) 0.5% solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic Gram-Positive Bacteria
Streptococcus mitis group*
Aerobic Gram-Negative Bacteria
*Efficacy for this organism was studied in fewer than 10 infections.
DOSAGE AND ADMINISTRATION
Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.
Dosage Forms And Strengths
Five (5) mL bottle containing 2.5 mL of a 0.5% sterile topical ophthalmic solution.
Storage And Handling
ZYMAXID™ (gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following sizes:
2.5 mL in 5 mL bottle: NDC 0023-3615-25
Store at 15°-25°C (59°-77°F). Protect from freezing.
Allergan, Inc. Irvine, CA 92612, U.S.A. Licensed from Kyorin Pharmaceuticals Co., Ltd.
Last reviewed on RxList: 6/23/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Zymaxid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.